.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Resistance to Aromatase Inhibitors in Breast Cancer
Alexey . Ed(S): Larionov
€ 128.72
FREE Delivery in Ireland
Description for Resistance to Aromatase Inhibitors in Breast Cancer
Hardback. Editor(s): Larionov, Alexey. Series: Resistance to Targeted Anti-Cancer Therapeutics. Num Pages: 304 pages, 29 black & white illustrations, 27 colour illustrations, 16 black & white tables, biograp. BIC Classification: MBGR; MFC; MJCL; MMG. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 19. Weight in Grams: 619.
Aromatase Inhibitors (AIs) treat postmenopausal estrogen receptor positive tumours, which constitute the majority of breast cancer patients. This comprehensive volume brings together the current knowledge from different relevant areas, including molecular mechanisms and translational aspects of drug resistance in AIs. Topics covered include research, experimental , and clinical data specifically focused on AI resistance in breast cancer. The volume will include three sections. The first section covers general knowledge about aromatase inhibitors, including regulation of aromatase genes, and structure and function of aromatase protein. The second section provides the detailed mechanisms of resistance to AIs, while the third section explores ... Read more
Aromatase Inhibitors (AIs) treat postmenopausal estrogen receptor positive tumours, which constitute the majority of breast cancer patients. This comprehensive volume brings together the current knowledge from different relevant areas, including molecular mechanisms and translational aspects of drug resistance in AIs. Topics covered include research, experimental , and clinical data specifically focused on AI resistance in breast cancer. The volume will include three sections. The first section covers general knowledge about aromatase inhibitors, including regulation of aromatase genes, and structure and function of aromatase protein. The second section provides the detailed mechanisms of resistance to AIs, while the third section explores ... Read more
Product Details
Format
Hardback
Publication date
2015
Publisher
Springer International Publishing AG Switzerland
Number of pages
304
Condition
New
Series
Resistance to Targeted Anti-Cancer Therapeutics
Number of Pages
288
Place of Publication
Cham, Switzerland
ISBN
9783319179711
SKU
V9783319179711
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
About Alexey . Ed(S): Larionov
Alexey Larionov, Ph.D. is a researcher at the Academic Laboratory of Medical Genetics and Statistics and Computational Biology Lab at the University of Cambridge. Dr Larionov is an expert in endocrine resistance in breast cancer, as well as whole exome sequencing data analysis. Dr. Larionov has received over 1019 citations.
Reviews for Resistance to Aromatase Inhibitors in Breast Cancer